These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression. Ni-Komatsu L; Orlow SJ Exp Eye Res; 2006 Mar; 82(3):519-28. PubMed ID: 16199032 [TBL] [Abstract][Full Text] [Related]
25. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism. Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098 [TBL] [Abstract][Full Text] [Related]
26. [Human oculocutaneous albinism. From clinical observation to molecular biology]. Aquaron R Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097 [TBL] [Abstract][Full Text] [Related]
27. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine. Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852 [TBL] [Abstract][Full Text] [Related]
28. Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism. Gershoni-Baruch R; Benderly A; Brandes JM; Gilhar A J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):220-2. PubMed ID: 1901069 [TBL] [Abstract][Full Text] [Related]
29. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual. Oetting WS; Fryer JP; King RA Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542 [No Abstract] [Full Text] [Related]
30. Tyrp1 and oculocutaneous albinism type 3. Sarangarajan R; Boissy RE Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055 [TBL] [Abstract][Full Text] [Related]
31. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity. Hearing VJ; Ekel TM; Montague PM; Hearing ED; Nicholson JM Arch Biochem Biophys; 1978 Jan; 185(2):407-18. PubMed ID: 415664 [No Abstract] [Full Text] [Related]
32. Genetic basis of pigmentation and its disorders. Klein LE; Nordlund JJ Int J Dermatol; 1981 Dec; 20(10):621-31. PubMed ID: 6799413 [No Abstract] [Full Text] [Related]
33. Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation. Beermann F; Orlow SJ; Boissy RE; Schmidt A; Boissy YL; Lamoreux ML Exp Eye Res; 1995 Nov; 61(5):599-607. PubMed ID: 8654502 [TBL] [Abstract][Full Text] [Related]
34. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism. Shimizu H Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668 [TBL] [Abstract][Full Text] [Related]
35. Recent progresses in understanding pigmentation. Kosmadaki MG; Naif A; Hee-Young P G Ital Dermatol Venereol; 2010 Feb; 145(1):47-55. PubMed ID: 20197745 [TBL] [Abstract][Full Text] [Related]
36. Mammalin tyrosinase. Stoichiometry and measurement of reaction products. Hearing VJ; Ekel TM; Montague PM; Nicholson JM Biochim Biophys Acta; 1980 Feb; 611(2):251-68. PubMed ID: 6766744 [TBL] [Abstract][Full Text] [Related]
37. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism. King RA; Oetting WS Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms governing melanogenesis in hamster melanomas: relative abundance of tyrosinase and catalase-B (gp 75). Slominski A; Costantino R; Howe J; Moellmann G Anticancer Res; 1991; 11(1):257-62. PubMed ID: 1673330 [TBL] [Abstract][Full Text] [Related]